Mind prep: could a coaching app boost brain rehab in MS?

NCT ID NCT07225868

Recruiting now Symptom relief Sponsor: Universiteit Leiden Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a coaching app that focuses on goal-directed behavior can make cognitive rehabilitation more effective for people with Multiple Sclerosis (MS). 126 participants will first use either the coaching app or a sham app for 12 weeks, then all will do 6 weeks of brain training. The goal is to see if personalized coaching improves memory, concentration, and daily functioning.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: conscientiousness coaching via app
What this could lead to: If it works, this could point toward a more personalized way to boost memory and concentration in people with MS.
What could go wrong: This is an early-stage study with only 126 participants, so results may not apply to everyone. The coaching is app-based, and its real-world impact is uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

multiple sclerosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MULTIPLE SCLEROSIS

Contacts and locations

Locations

Health, Medical and Neuropsychology, Institute of Psychology, Faculty of Behvavioural and Social Siences, Leiden University
RECRUITING

Leiden, 2333AK, Netherlands
Jacobs School of Medicine and Biomedical Sciences, Neurology, University at Buffalo
NOT_YET_RECRUITING

Buffalo, New York, 14203, United States
Research Department, Reha Rheinfelden
NOT_YET_RECRUITING

Rheinfelden, 4310, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.